SMShinichiro Masuda

Shinichiro Masuda

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shinichiro Masuda has a total of 100 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Eosinophilic granulomatosis with polyangiitis related giant coronary aneurysm leading to acute myocardial infarction: a case report

    by Kosei Okamoto, Shinichiro Masuda, Kenji Takagi, Nobuhiko Ogata, Takaaki Isshiki

    Background: Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare, multisystem autoimmune disorder characterized by adult-onset asthma, peripheral eosinophilia, and small- to medium-vessel vasculitis. Cardiac involvement is a leading cause of mortality in EGPA. A case exhibiting progressive enlargement of coronary aneurysms despite normal peripheral eosinophil counts and treatment consistent with guideline-recommended immunosuppressive therapy is exceedingly rare. Case summary: A 55-year-old woman with a 7-year history of EGPA presented to our institution with acute chest pain. Four years prior to the current presentation, the patient underwent coronary angiography for acute coronary syndrome at another hospital, which revealed coronary ectasia. Consequently, low-dose aspirin was initiated as secondary prevention. Following the diagnosis of EGPA, guideline-directed immunosuppressive therapy was maintained. Throughout the 4-year follow-up period, her peripheral eosinophil counts remained within the normal range. An emergent coronary angiography, prompted by a diagnosis of non-ST-elevation myocardial infarction, demonstrated progression to a giant coronary aneurysm. Coronary computed tomography angiography also showed thrombus within the dilated coronary artery. Given the likely aetiology of coronary thrombosis, anticoagulation therapy with warfarin was initiated in addition to her ongoing aspirin regimen. The patient remained clinically stable during hospitalization, experienced no recurrent chest pain, and was discharged on the fourth day. Discussion: We reported a rare case of an EGPA-related coronary artery aneurysm longitudinally monitored through serial coronary angiography. This case demonstrates that EGPA-related coronary aneurysms may progress despite adherence to therapeutic guidelines and persistently normal eosinophil counts, emphasizing the importance of continuous imaging surveillance and individualized management strategies.


  • Open Access

    Ventricular fibrillation due to coronary vasospasm triggered by hyperventilation in a patient with panic disorder: case report

    by Shota Takimoto, Shinichiro Masuda, Shuzou Tanimoto, Nobuhiko Ogata, Takaaki Isshiki

    Background: Panic attacks can trigger hyperventilation, which has been associated with the induction of coronary vasospasm. The resulting vasospasm may cause myocardial ischaemia and trigger life-threatening arrhythmias. Patients with panic disorders experiencing hyperventilation sometimes present with symptoms similar to those of acute coronary syndrome, making it difficult to determine their origin. Case summary: A 37-year-old man with a history of panic disorder was transported to our institute after he experienced hyperventilation during a panic attack and developed chest pain and a subsequent loss of consciousness. During transportation, ventricular fibrillation was observed on electrocardiography, and sinus rhythm was successfully restored with defibrillation. Suspecting hyperventilation-induced coronary vasospasm, a hyperventilation test was performed, which induced 90% coronary spasm accompanied by chest pain. An acetylcholine (ACh) provocation test revealed total occlusion of the left main bifurcation, with significant ischaemic ST-T elevation. Medication with a calcium channel blocker (nifedipine 40 mg per day), nitrate (isosorbide dinitrate 40 mg per day), and statin (rosuvastatin 20 mg per day) was initiated. Three months later, a repeat ACh provocation test performed to assess response to the medications revealed 90% stenosis with ischaemic ST-T changes and chest discomfort. Subsequently, a subcutaneous cardioverter defibrillator was implanted to address refractory vasospastic angina. Discussion: Herein, ventricular fibrillation was likely caused by coronary spasm induced by hyperventilation during the panic attack. Regarding the management of patients with panic disorder who present with chest pain, clinicians should carefully assess the symptoms and consider hyperventilation-induced coronary spasm as a differential diagnosis.

  • Open Access

    Coronary bypass surgery guided by computed tomography in a low-risk population

    by Patrick W Serruys, Shigetaka Kageyama, Giulio Pompilio, Daniele Andreini, Gianluca Pontone, Saima Mushtaq, Mark La Meir, Johan De Mey, Kaoru Tanaka, Torsten Doenst, et al.

    Background and Aims: In patients with three-vessel disease and/or left main disease, selecting revascularization strategy based on coronary computed tomography angiography (CCTA) has a high level of virtual agreement with treatment decisions based on invasive coronary angiography (ICA).Methods: In this study, coronary artery bypass grafting (CABG) procedures were planned based on CCTA without knowledge of ICA. The CABG strategy was recommended by a central core laboratory assessing the anatomy and functionality of the coronary circulation. The primary feasibility endpoint was the percentage of operations performed without access to the ICA. The primary safety endpoint was graft patency on 30-day follow-up CCTA. Secondary endpoints included topographical adequacy of grafting, major adverse cardiac and cerebrovascular (MACCE), and major bleeding events at 30 days. The study was considered positive if the lower boundary of confidence intervals (CI) for feasibility was ≥75% (NCT04142021).Results: The study enrolled 114 patients with a mean (standard deviation) anatomical SYNTAX score and Society of Thoracic Surgery score of 43.6 (15.3) and 0.81 (0.63), respectively. Unblinding ICA was required in one case yielding a feasibility of 99.1% (95% CI 95.2%–100%). The concordance and agreement in revascularization planning between the ICA- and CCTA-Heart Teams was 82.9% with a moderate kappa of 0.58 (95% CI 0.50–0.66) and between the CCTA-Heart Team and actual treatment was 83.7% with a substantial kappa of 0.61 (95% CI 0.53–0.68). The 30-day follow-up CCTA in 102 patients (91.9%) showed an anastomosis patency rate of 92.6%, whilst MACCE was 7.2% and major bleeding 2.7%.Conclusions: CABG guided by CCTA is feasible and has an acceptable safety profile in a selected population of complex coronary artery disease.


  • Precise Assessments of Dissection Following Drug-Coated Balloon Treatment and Its Impact on Clinical Outcomes in De Novo Small Vessel Disease

    by Kai Ninomiya, Patrick Serruys, Shinichiro Masuda, Jiayue Huang, Ding Daixin, Nozomi Kotoku, Shigetaka Kageyama, Manish Doshi, William Wijns, Shengxian Tu, et al.

  • TCTAP A-043 Precise Assessments of Dissection Following Drug-Coated Balloon Treatment and Its Impact on Clinical Outcomes in de Novo Small Vessel Disease

    by Kai Ninomiya, Patrick W. Serruys, Jiayue Huang, Shinichiro Masuda, Daixin Ding, Nozomi Kotoku, Shigetaka Kageyama, Shengxian Tu, William Wijns, Jouke Dijkstra, et al.

  • CRT-600.05 Precise Assessments of Dissection Following Drug-Coated Balloon Treatment and Its Impact on Clinical Outcomes in De Novo Small Vessel Disease

    by Kai Ninomiya, Patrick Serruys, Shinichiro Masuda, Jiayue Huang, Ding Daixin, Nozomi Kotoku, Shigetaka Kageyama, Manish Doshi, William Wijns, Shengxian Tu, et al.


  • Open Access

    Angiographic derived physiological assessment after intervention for predicting 2-year vessel-oriented composite endpoints in Multivessel TALENT trial

    by S Kageyama, P W Serruys, S Masuda, K Ninomiya, N Kotoku, Y Onuma

    Aims: The purpose of the study is to assess the treatment results in the first 200 patients in the ongoing Multivessel TALENT trial and to predict the vessel-oriented endpoint by assessing the quantitative flow ratio (QFR) post PCI in a central independent core laboratory. Methods: In this prospective, randomized, 1:1 balanced, multi-centre, open-label trial, de novo multivessel coronary artery disease patients without left main disease are assigned to the sirolimus-eluting stent or everolimus-eluting stent arm. The percutaneous coronary intervention (PCI) is planned based on functional lesion evaluation by QFR provided by the Core laboratory and the PCI has to be optimized by intravascular imaging, optimal pharmacological treatment and prasugrel monotherapy. Results: Mean age of the population was 66.6±14.7 years, and 78.1% of them were male. This population consists of 17.4% unstable angina and of 31.8% diabetic patients. Anatomical SYNTAX score was 18.8±9.1. Total 458 lesions were treated from September 2020 to December 2021. Left anterior descending artery accounts for 40.3%, bifurcation lesion was present in 40.8%, total occlusion in 4.2%. The average stent diameter and total stent length were 3.0±0.4mm and 38.7±22.4mm, respectively. Intravascular imaging was used in 92.8% of treated vessels (intravascular ultrasound 56.5%, optical coherent tomography 36.3%). Pre-PCI QFR was analysable in 435 vessels (0.59±0.21), and 5.5% of them were treated even though the pre-PCI QFR values were more than 0.8. Post-PCI QFR has been so far analysed in 303 vessels (0.93±0.11) and 79.5% of them achieved a post-PCI QFR equal or superior to 0.91. Based on the previous study [1], Two-year vessel-oriented composite endpoint (VOCE) was estimated to become 5.4% in the present study population (3.7% in the patient group that achieved post PCI QFR equal or superior to 0.91, while 12% in the patients who could not reach the threshold), which was almost equal to what is expected in the power calculation. Conclusions: In the Multivessel TALENT trial, the large majority of the vessels treated (94.5%) complied with the hemodynamic criteria of recommended PCI as provided by the QFRs of the Core laboratory. Favourable post-PCI QFR (≥0.91) obtained in 80% of the patients let expected a favourable VOCE outcome of 5.4%. Funding Acknowledgement: Type of funding sources: Public Institution(s). Main funding source(s): The National University of Ireland Galway

  • Open Access

    Impact of bifurcation lesion on 10-year mortality in the SYNTAX trial

    by K Ninomiya, P W Serruys, S Garg, C Gao, S Masuda, M Lunardi, F Burzotta, M C Morice, A Colombo, M J Mack, et al.

    Background: Percutaneous coronary intervention (PCI) of bifurcation lesions is associated with higher rates of adverse events, and currently it is unclear whether PCI or coronary artery bypass grafting (CABG) is the safer treatment for these patients at very long-term follow up. Objectives: To investigate the impact of bifurcation lesions on observed all-cause 10-year mortality in the SYNTAX trial. Methods: In the SYNTAX Extended Survival study, 10-year observed mortality was compared among four groups: (a) presence of ≥1 bifurcation lesion and treatment with PCI (n=649), (b) no bifurcation lesion and treatment with PCI (n=248), (c) presence of ≥1 bifurcation lesion and treatment with CABG (n=651), and (d) no bifurcation lesion and treatment with CABG (n=239). Results: Compared to patients without bifurcations, those with bifurcation lesion(s) treated with PCI had a significantly higher risk of all-cause death (19.8% vs 30.1%; HR: 1.55, 95% CI: 1.12 to 2.14; p=0.007), whereas following CABG, mortality was similar in patients with or without bifurcation lesion(s) (23.3% vs 23.0%; HR: 0.81, 95% CI: 0.59 to 1.12; p=0.207). (Figure1) There was a significant interaction between bifurcation lesion(s) and treatment arm (p for interaction=0.006). In PCI patients, at 5-years there was no significant difference in mortality between 1- vs 2-stent techniques, whereas at 10-years, a 2-stent technique was associated with higher mortality (33.3% vs 25.9%; HR: 1.51, 95% CI: 1.06 to 2.14; p=0.021, Figure2). Conclusions: Bifurcation lesion(s) require special attention from the heart team discussion, considering the higher 10-year all-cause mortality associated with PCI. Careful evaluation of bifurcation lesion complexity may be helpful in decision-making. Funding Acknowledgement: Type of funding sources: Private grant(s) and/or Sponsorship. Main funding source(s): The SYNTAX Extended Survival study was supported by the German Foundation of Heart Research (Frankfurt am Main, Germany). The SYNTAX trial, during 0-5 years follow-up, was funded by Boston Scientific Corporation (Marlborough, MA, USA). Both sponsors had no role in the study design, data collection, data analyses, and interpretation of the study data, nor were involved in the decision to publish the final manuscript. The principal investigators and authors had complete scientific freedom.

  • Open Access

    Appropriateness of the modality of revascularization according to the SYNTAX 2020 in the FASTTRACK CABG study

    by K Ninomiya, P W Serruys, S Masuda, S Kageyama, N Kotoku, Y Onuma

    Objectives: To compare the modality of revascularization selected by the local heart team to the one recommended by the core laboratory according to the SYNTAX score 2020 amongst patients with three-vessel disease (3VD) with or without left main disease (LMCAD), who were allocated to CABG planned and solely guided by coronary computerized tomographic angiography in the FASTTRACK CABG trial. Background: Personalized long term vital prognosis plays a key role in deciding between PCI and coronary artery bypass grafting (CABG) in patients with complex coronary artery disease. Methods: In an interim analysis requested by the Data Safety Monitoring Board the treatment recommendations according to the SYNTAX 2020 were prospectively assessed in 57 consecutive patients (half of the planned population in this First in Man) by a core laboratory and compared to the decision of the “on site” heart team. Results: According to SS-2020, the predicted absolute risk difference (ARD) in mortality between the virtual PCI treatment population and the CABG treatment group, which can be considered a virtual surrogate for the average treatment effect, increased with the duration of follow up, from 4.8±3.5% at 5 years to 8.8±5.1% at 10 years (Table 1). The ARD of less than 0% in mortality at 5-year in favour of PCI was only documented in two patients while the 55 remaining patients had a predicted survival benefit over PCI if receiving CABG. However, based on a novel threshold of equipoise (ARD <4.5%) recently validated in a contemporary registry of 3VD and LMCAD, CABG was mandatory in 26 (45.6%) patients, whereas PCI or CABG could have been equally selected in 31 (54.4%) patients (Figure 1). Conclusions: According to the SYNTAX Score 2020 there was a strict observance of the CABG treatment recommendation in the first 57 consecutive patients with 3VD or LMCAD, screened on site in the FAST TRACK CABG trial. The more lenient selection criteria derived from the contemporary regitry will have to be tested propectively. Application of artificial intelligence with expanded collection of baseline characteristics, scientific endorsement and regulatory enforcement as well as further prospective evaluation are the challenges of future decision-making scores, that should be ultimately shared with the patients. Funding Acknowledgement: Type of funding sources: None.

  • Open Access

    Comparison of the SYNTAX score 2020 based on Coronary Artery Computed Tomography (CCTA) with Invasive Coronary Angiography (ICA)

    by S Masuda, S Kageyama, N Kotoku, K Ninomiya, U Schneider, T Doenst, K Tanaka, J D Mey, M Lameir, S Mushtaq, et al.

    Introduction: The SYNTAX III REVOLUTION trial demonstrated that clinical decision-making between coronary artery bypass graft (CABG) and percutaneous coronary intervention (PCI) based on coronary artery computed tomography (CCTA) and predicting four years mortality according to the SYNTAX score II had a high agreement with the treatment decision derived from invasive coronary angiography (ICA). The agreement of the novel SYNTAX score 2020 (SS-2020) based on CCTA and ICA has not yet been evaluated in a prospective fashion. Methods: This study included 54 consecutive patients in the ongoing FASTTRACK CABG trial that investigates decision making, planning and procedural CABG guidance based solely on CCTA and FFRct. All the patients underwent CCTA and ICA, and SS-2020 was calculated based on the results of anatomical SYNTAX score derived from either CCTA or ICA, and the respective scores were compared by using paired t-test. Results: The mean age was 67.3±9.7, and 48 were men (88.9%). Anatomical SYNTAX score derived from CCTA was assessed in the 54 cases (analysability 100%). Anatomical SYNTAX scores based on CCTA and ICA were 34.3±9.3, and 35.5±11.3, respectively (P=0.480). As shown in the table predicted 5 years major adverse cardiac and cerebrovascular events (MACCE) following either PCI or CABG, as well as predicted 10 years mortality following CABG differed significantly. However the absolute risk differences (ARD) in 5 years MACCE and 10 years mortality following either PCI or CABG, were comparable. Conclusions: High agreements were confirmed in the calculations of anatomical SYNTAX scores with CCTA and ICA. Despite significant differences in predicted MACCE rates at 5 years and mortalities at 10 years, the ARD in MACCE rates and mortality were comparable. In terms of treatment decision-making, SS-2020 calculations based on CCTA is a non-invasive predictive tool comparable to the one based on ICA. Funding Acknowledgement: Type of funding sources: None.